Cellect Biotechnology Ltd. (NASDAQ:APOP) investors are busy throwing a party today following the news that the stem cell developer has achieved a major …
US-based biotechnology firm Capricor Therapeutics Inc (NASDAQ:CAPR) announced that the American Heart Association (AHA) Scientific Sessions 2017 has accepted for presentation at a late-breaking session the …
Cory Kasimov: GILD’s Phase II study data may be early, but first signs speak to a well-tolerated treatment.
Oren Livnat believes MNKD’s revised debt arrangements will be advantageous to the Afrezza launch.
Eric Schmidt views BIIB shares as undervalued based upon a stable MS franchise and Spinraza’s potential.
Pain Therapeutics, Inc. (NASDAQ:PTIE) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 60% …
Elemer Piros reaffirms his bullish thesis on AUPH after a compelling R&D day mapping the next 24 months.
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced additional results of the phase 2 clinical trial with obeticholic acid (OCA), a potent farnesoid X receptor agonist …
It’s a very rewarding trading day for Aimmune Therapeutics Inc (NASDAQ:AIMT) investors with shares up over 30%, making the stock Wall Street’s bull …
DBV Technologies SA – ADR (NASDAQ:DBVT) saw its shares crater by as much as 45% today on exceptionally high volume. This drop was …
